文献速递肝胆胰外科围术期管理与 ERAS

肝肾胰手术免输血策略:主流人群避免输血的预测模型

Transfusion-free Strategies in Liver and Pancreatic Surgery: A Predictive Model of Blood Conservation for Transfusion Avoidance in Mainstream Populations.
PubMed 文献 · Ann Surg · 2022-11-17

结果显示无围术期死亡,肝切除Clavien≥3级并发症为7.0%,胰腺切除为15.9%。

要点

  • 对耶和华见证人患者实施肝胰大切除,通过围术期管理可实现免输血。
  • ANH术中移除全血,保留红细胞、血小板和凝血因子,按需或术毕回输。
  • 肝切除Clavien≥3级并发症7.0%,胰腺切除15.9%,无围术期死亡。

核心结论

  • 精心围术期管理可使肝和胰腺切除免输血可行。
  • ANH术中移除全血可保留红细胞、血小板和凝血因子以备及时回输。
  • 该免输血策略可推广至更广泛人群,以降低用血成本和并发症。

研究设计与样本

  • 23年单中心回顾性综述,纳入接受肝和胰腺切除的耶和华见证人患者。
  • 描述围术期管理与患者结局,并提出ANH量化数学公式指导使用。

主要发现

  • 移除的全血按需用于出血或术毕回输。
  • 无围术期死亡;Clavien≥3级并发症肝切除7.0%,胰腺切除15.9%。

关键数值与推荐

  • ANH中位移除2单位全血,按需或术毕回输。
  • 肝切除Clavien≥3级并发症发生率7.0%。
  • 胰腺切除Clavien≥3级并发症发生率15.9%。

临床怎么用

  • 对不接受异体输血的患者,可考虑ANH保留全血以备回输。
  • 围术期管理应系统规划,以抵消手术失血并避免异体输血。
  • ANH的量化公式可用于指导临床实践。

局限性

  • 单中心回顾性研究,证据等级有限。
  • 研究对象为耶和华见证人患者,外推至主流人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study is to (1) describe the techniques and prove the feasibility of performing complex hepatobiliary and pancreatic surgery on a Jehovah Witness (JW) population. (2) Describe a strategy that offsets surgical blood loss by the manipulation of circulating blood volume to create reserve whole blood upon anesthesia induction. BACKGROUND: Major liver and pancreatic resections often require operative transfusions. This limits surgical options for patients who do not accept major blood component transfusions. There is also growing recognition of the negative impact of allogenic blood transfusions. METHODS: A 23-year, single-center, retrospective review of JW patients undergoing liver and pancreatic resections was performed. We describe perioperative management and patient outcomes. Acute normovolemic hemodilution (ANH) is proposed as an important strategy for offsetting blood losses and preventing the need for blood transfusion. A quantitative mathematical formula is developed to provide guidance for its use. RESULTS: One hundred one major resections were analyzed (liver n=57, pancreas n=44). ANH was utilized in 72 patients (liver n=38, pancreas n=34) with median removal of 2 units that were returned for hemorrhage as needed or at the completion of operation. There were no perioperative mortalities. Morbidity classified as Clavien grade 3 or higher occurred in 7.0% of liver resection and 15.9% of pancreatic resection patients. CONCLUSIONS: Deliberate perioperative management makes transfusion-free liver and pancreatic resections feasible. Intraoperative whole blood removal with ANH specifically preserves red cell mass, platelets, and coagulation factors for timely reinfusion. Application of the described JW transfusion-free strategy to a broader general population could lessen blood utilization costs and morbidities.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Kulkarni S, Parina R, Henderson R, et al. Transfusion-free Strategies in Liver and Pancreatic Surgery: A Predictive Model of Blood Conservation for Transfusion Avoidance in Mainstream Populations. Ann Surg. 2022. PMID: 36538643. doi:10.1097/SLA.0000000000005757

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。